WertQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMMittelzufluss aus Investitionstätigkeit-233 K-448 K-98 K-8 000-3 000-557 KZahlungsströme aus der Finanzierungstätigkeit67 K171 K1.48 M78.09 M25.22 M104.96 MFreier Cashflow-17.27 M-25.53 M-21.3 M-22.72 M-21.34 M-90.89 M
Fractyl Health Inc
Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1.